Oxford Biomedica plc (OXB.L) LSE

919.43

+115.4325(+14.36%)

Updated at January 15 03:30PM

Currency In GBp

Valuation

Market Cap434.52M
Enterprise Value482.64M
P/E Ratio-26.3
PEG Ratio-1.8
Price/Sales Ratio7.34
Price/Book Ratio29.78
Enterprise/Revenue7.68
Enterprise/EBITDA-1,080.72

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin-0.25
Operating Margin-0.22

Management Effectiveness

Return On Assets-0.17
Return On Equity-0.83

Income Statement

Revenue128.8M
Revenue/Share1.43
Gross Profit53.02M
EBITDA-14.33M
Net Income-43.19M
Diluted EPS-0.42

Balance Sheet

Total Cash53.88M
Total Cash/Share0.51
Total Debt105.42M
Total Debt/Equity3.22
Current Ratio1.89
Book Value Per Share0.31

Price History

52-Week Change129
52-Week High952
52-Week Low232.5
Moving Average 50 Days634.28
Moving Average 200 Days485.46

Statistics

Average Volume275,716
Shares Outstanding106.06M
% Held by Institutions2.36

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:50
Last Split DateMay 30, 2018